Lumateperone - Intra-Cellular Therapies
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Licenced by Intra-Cellular Therapies
- Drug Class Antidementias; Antidepressants; Antipsychotics; Behavioural disorder therapies; Fluorobenzenes; Mood stabilisers; Piperidines; Pyrroles; Quinoxalines; Sleep disorder therapies; Small molecules; Tosyl compounds
- Mechanism of Action Dopamine D2 receptor modulators; Glutamate modulators; Serotonin 5-HT2A receptor antagonists; Serotonin uptake inhibitors
- USA Patent Applicants INTRA-CELLULAR
- USA Patents 37
- NDAs 1
- International Patents 167
- Patent Applications 67
Disclaimer